ArticlePharmacoEconomics - open2021

Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France.

Bruno Detournay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.